Results from this analysis reveal important differences in the dynamics of ctDNA beyond PD-L1 expression and TMB and its relationship with clinical outcomes that may reflect the differing mechanisms of action of the treatment and the effects on the dynamics of tumor growth and tumor cell killing. The gene discussed is CD274; the disease is neoplasm.